{"nctId":"NCT02885636","briefTitle":"Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial","startDateStruct":{"date":"2016-09"},"conditions":["Congestive Heart Failure","Heart Failure, Left-Sided","Left-Sided Heart Failure"],"count":30,"armGroups":[{"label":"Inhaled albuterol","type":"EXPERIMENTAL","interventionNames":["Drug: Albuterol"]},{"label":"Inhaled saline placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Saline placebo"]}],"interventions":[{"name":"Albuterol","otherNames":["Proventil, AccuNeb, Proair, Ventolin, and Vospire"]},{"name":"Saline placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Heart Failure with Preserved Ejection Fraction (HFpEF)\n* Normal left ventricular ejection fraction (≥50%)\n* Elevated Left Ventricular filling pressures at cardiac catheterization (defined as resting Pulmonary Capillary Wedge Pressure\\>15 mmHg and/or ≥25 mmHg during exercise).\n\nExclusion Criteria:\n\n* Prior albuterol therapy (within previous 48 hours)\n* Current long acting inhaled beta agonist use\n* Significant hypokalemia (\\<3meq/L)\n* Significant valvular disease (\\>moderate left-sided regurgitation, \\>mild stenosis)\n* High output heart failure\n* Severe pulmonary disease\n* Unstable coronary disease\n* Constrictive pericarditis\n* Restrictive cardiomyopathy\n* Hypertrophic cardiomyopathy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in 20 Watt Exercise Pulmonary Vascular Resistance (PVR)","description":"The exercise PVR at 20 Watts after study drug relative to the exercise PVR at 20 Watts in the initial assessment prior to study drug. This measurement is made by subtracting pulmonary capillary wedge pressure from the mean pulmonary arterial pressure and dividing by cardiac output in liters per minute and reported as wood units. A decrease in PVR measured by wood units would be considered a favorable response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"0.5"},{"groupId":"OG001","value":"0.1","spread":"0.7"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Pulmonary Vascular Resistance","description":"The resting PVR after study drug relative to the resting PVR in the initial assessment prior to study drug. This measurement is made by subtracting pulmonary capillary wedge pressure from the mean pulmonary arterial pressure and dividing by cardiac output in liters per minute and reported as wood units.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"0.5"},{"groupId":"OG001","value":"-0.3","spread":"0.8"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Pulmonary Capillary Wedge Pressure (PCWP)","description":"Pulmonary capillary wedge pressure was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter. PCWP position was confirmed by appearance on fluoroscopy, characteristic pressure waveforms, and oximetry.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2","spread":"6"},{"groupId":"OG001","value":"-3","spread":"3"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Pulmonary Capillary Wedge Pressure (PCWP)","description":"Pulmonary capillary wedge pressure was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter. PCWP position was confirmed by appearance on fluoroscopy, characteristic pressure waveforms, and oximetry.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2","spread":"2"},{"groupId":"OG001","value":"-2","spread":"3"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Pulmonary Artery Compliance","description":"Pulmonary artery compliance was calculated as the ratio of stroke volume/pulmonary artery pulse pressure.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":"1.6"},{"groupId":"OG001","value":"0.0","spread":"0.7"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Pulmonary Artery Compliance","description":"Pulmonary artery compliance was calculated as the ratio of stroke volume/pulmonary artery pulse pressure.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"1.0"},{"groupId":"OG001","value":"0.7","spread":"1.0"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Pulmonary Artery Pressure","description":"Pulmonary artery pressure was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8","spread":"4"},{"groupId":"OG001","value":"-2","spread":"4"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Pulmonary Artery Pressure","description":"Pulmonary artery pressure was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5","spread":"3"},{"groupId":"OG001","value":"-3","spread":"3"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Right Atrial Pressure (RA)","description":"RA was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5","spread":"3"},{"groupId":"OG001","value":"-1","spread":"2"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Right Atrial Pressure (RA)","description":"RA was measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3","spread":"2"},{"groupId":"OG001","value":"-1","spread":"2"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Cardiac Output","description":"Cardiac output was calculated using the direct Fick method of breath-by-breath oxygen consumption (V02)/arterial-venous oxygen content difference (AVO2 diff).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"2.1"},{"groupId":"OG001","value":"0.1","spread":"1.0"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Cardiac Output","description":"Cardiac output was calculated using the direct Fick method of breath-by-breath oxygen consumption (V02)/arterial-venous oxygen content difference (AVO2 diff).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"1.2"},{"groupId":"OG001","value":"0.4","spread":"1.2"}]}]}]},{"type":"SECONDARY","title":"Change in Exercise Pulmonary Elastance","description":"Pulmonary elastance was calculated by the ratio of pulmonary artery systolic pressure/stroke volume.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.17","spread":"0.11"},{"groupId":"OG001","value":"-0.05","spread":"0.11"}]}]}]},{"type":"SECONDARY","title":"Change in Resting Pulmonary Elastance","description":"Pulmonary elastance was calculated by the ratio of pulmonary artery systolic pressure/stroke volume.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":"0.13"},{"groupId":"OG001","value":"-0.03","spread":"0.13"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":[]}}}